Market Place
Sourcing Support
GenomOncology, OHSU Knight Lab Accelerate Precision Oncology
14 Jan 2026 //
PR NEWSWIRE
Genomoncology Teams Up With Glioblastoma Foundation
11 Nov 2025 //
PR NEWSWIRE
GenomOncology Announces BioMCP: Open Source Model Context Protocol
10 Apr 2025 //
PR NEWSWIRE
GenomOncology partners Chronetyx Labs to accelerate cancer care
31 Mar 2025 //
PR NEWSWIRE
Belay Diagnostics partners GenomOncology for CNS cancer test
25 Mar 2025 //
PR NEWSWIRE
Meditech & GenomOncology Drive Targeted Cancer Care At Frederick
27 Feb 2025 //
BUSINESSWIRE
GenomOncology & Pillar Biosciences Partner For Precision Oncology
13 Feb 2025 //
PR NEWSWIRE
GenomOncology Appoints Dr. Jack Lord to Board of Directors
19 Dec 2024 //
PR NEWSWIRE
GenomOncology & Genomen Partner on Germline Variant Classification
07 Nov 2024 //
PR NEWSWIRE
GenomOncology Partners With Precipio For Myeloid Testing
10 Sep 2024 //
PR NEWSWIRE
GenomOncology Expands Germline Testing Support in GO Pathology Workbench
29 Apr 2024 //
PR NEWSWIRE
GenomOncology`s Data IgniteIQ to Advance Natural Language Processing Pipeline
28 Nov 2023 //
PR NEWSWIRE
GenomOncology Welcomes Garreth Hippe as Chief Commercial Officer
03 Oct 2023 //
PR NEWSWIRE
GenomOncology, Congenica announce collaborative development
04 Aug 2022 //
PRNEWSWIRE
GenomOncology Selected by Personalis to Support MRD and SNV Analysis
12 Jul 2022 //
PRNEWSWIRE
GenomOncology Boosts Capabilities with Prior Intervention Eligibility Criteria
16 Jun 2022 //
PRNEWSWIRE
GenomOncology Bolsters Board of Directors with CEO of 1Password
04 Apr 2022 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.